本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

17.73
+0.01000.06%
成交量:66.94万
成交额:1,188.84万
市值:22.66亿
市盈率:102.84
高:17.98
开:17.62
低:17.48
收:17.72
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.27
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
净资产收益率:7.48%
总资产收益率:3.53%
市净率:6.12
市盈率(LYR):102.84

数据加载中...

2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities